NO20002167L - Anti-østrogen pluss progestin-inneholdende orale befruktningshindrende midler - Google Patents

Anti-østrogen pluss progestin-inneholdende orale befruktningshindrende midler

Info

Publication number
NO20002167L
NO20002167L NO20002167A NO20002167A NO20002167L NO 20002167 L NO20002167 L NO 20002167L NO 20002167 A NO20002167 A NO 20002167A NO 20002167 A NO20002167 A NO 20002167A NO 20002167 L NO20002167 L NO 20002167L
Authority
NO
Norway
Prior art keywords
oral contraceptives
containing oral
estrogen plus
plus progestin
progestin
Prior art date
Application number
NO20002167A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002167D0 (no
Inventor
Michael Jay Gast
Christopher Paul Miller
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO20002167D0 publication Critical patent/NO20002167D0/no
Publication of NO20002167L publication Critical patent/NO20002167L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20002167A 1997-11-06 2000-04-27 Anti-østrogen pluss progestin-inneholdende orale befruktningshindrende midler NO20002167L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96508397A 1997-11-06 1997-11-06
PCT/US1998/023427 WO1999024027A2 (en) 1997-11-06 1998-11-04 Anti-estrogen plus progestin containing oral contraceptives

Publications (2)

Publication Number Publication Date
NO20002167D0 NO20002167D0 (no) 2000-04-27
NO20002167L true NO20002167L (no) 2000-06-28

Family

ID=25509417

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002167A NO20002167L (no) 1997-11-06 2000-04-27 Anti-østrogen pluss progestin-inneholdende orale befruktningshindrende midler

Country Status (28)

Country Link
EP (1) EP1051179B1 (id)
JP (1) JP2001522798A (id)
CN (1) CN1278732A (id)
AR (1) AR016667A1 (id)
AT (1) ATE304359T1 (id)
AU (2) AU760540B2 (id)
BG (1) BG104451A (id)
BR (1) BR9813982A (id)
CA (1) CA2307210A1 (id)
CZ (1) CZ294155B6 (id)
DE (1) DE69831605T2 (id)
DK (1) DK1051179T3 (id)
EA (1) EA200000492A1 (id)
EE (1) EE04092B1 (id)
ES (1) ES2246541T3 (id)
GE (1) GEP20043290B (id)
HR (1) HRP20000269A2 (id)
HU (1) HUP0100293A3 (id)
ID (1) ID24568A (id)
IL (1) IL135621A0 (id)
NO (1) NO20002167L (id)
NZ (1) NZ503890A (id)
PL (1) PL340623A1 (id)
SK (1) SK6482000A3 (id)
TR (1) TR200001268T2 (id)
UA (1) UA68365C2 (id)
WO (1) WO1999024027A2 (id)
ZA (1) ZA9810136B (id)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
HRP20000778B1 (en) * 1998-05-15 2004-10-31 Wyeth Corp 2-phenyl-1-/4-(2-aminoethoxy)-benzyl/-indole in combination with estrogens
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
NZ517645A (en) * 1999-09-13 2003-09-26 Wyeth Corp Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1- [4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
SK622004A3 (en) 2001-07-31 2004-08-03 Pfizer Prod Inc Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
AU2005302706B2 (en) * 2004-10-27 2011-12-15 Janssen Pharmaceutica N.V. Indole derivatives useful as progesterone receptor modulators
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
UY29527A1 (es) * 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
DE102008057230A1 (de) * 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
BR112012031464A2 (pt) 2010-06-10 2020-08-04 Aragon Pharmaceuticals, Inc. moduladores do receptor de estrogênio e os seus usos
SG11201403002RA (en) 2011-12-14 2014-07-30 Seragon Pharmaceuticals Inc Fluorinated estrogen receptor modulators and uses thereof
KR102710603B1 (ko) 2015-10-01 2024-09-27 올레마 파마슈티컬스 인코포레이티드 테트라히드로-1H-피리도[3,4-b]인돌 항에스트로겐 약물
NZ743651A (en) 2015-12-09 2023-07-28 Univ Illinois Benzothiophene-based selective estrogen receptor downregulators
ES2989988T3 (es) 2016-05-10 2024-11-28 C4 Therapeutics Inc Degronímeros heterorocíclicos para la degradación de proteínas diana
WO2017197051A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Amine-linked c3-glutarimide degronimers for target protein degradation
WO2017197046A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. C3-carbon linked glutarimide degronimers for target protein degradation
CN109562113A (zh) 2016-05-10 2019-04-02 C4医药公司 用于靶蛋白降解的螺环降解决定子体
EA201990187A1 (ru) 2016-07-01 2019-07-31 Г1 Терапьютикс, Инк. Антипролиферационные средства на основе пиримидина
WO2018081168A2 (en) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
TWI823845B (zh) 2017-01-06 2023-12-01 美商G1治療公司 用於治療癌症的組合療法
WO2018148576A1 (en) 2017-02-10 2018-08-16 G1 Therapeutics, Inc. Benzothiophene estrogen receptor modulators
CN110769822A (zh) 2017-06-20 2020-02-07 C4医药公司 用于蛋白降解的n/o-连接的降解决定子和降解决定子体
EP4455146A3 (en) 2017-06-29 2025-01-01 G1 Therapeutics, Inc. Morphic forms of git38 and methods of manufacture thereof
CN120698983A (zh) 2018-12-20 2025-09-26 C4医药公司 靶向蛋白降解
JP7616794B2 (ja) 2019-07-07 2025-01-17 オレマ ファーマシューティカルズ インク． エストロゲン受容体アンタゴニストのレジメン
MX2022007659A (es) 2019-12-20 2022-07-19 C4 Therapeutics Inc Compuestos de isoindolinona e indazol para la degradacion del receptor del factor de crecimiento epidermico (egfr).
MX2022010952A (es) 2020-03-05 2022-10-07 C4 Therapeutics Inc Compuestos para la degradacion dirigida de brd9.
JP2023538517A (ja) 2020-08-05 2023-09-08 シーフォー セラピューティクス， インコーポレイテッド Ｒｅｔの標的分解のための化合物
CN117940133A (zh) 2021-06-08 2024-04-26 C4医药公司 用于突变braf的降解的治疗剂
EP4565585A1 (en) 2022-08-03 2025-06-11 Bristol-Myers Squibb Company Compounds for modulating ret protein
CN120530116A (zh) 2022-11-04 2025-08-22 百时美施贵宝公司 Ret-ldd蛋白抑制剂
JP2025540907A (ja) 2022-11-04 2025-12-17 ブリストル－マイヤーズ スクイブ カンパニー Ｒｅｔ－ｌｄｄタンパク質分解誘導剤
WO2025006753A2 (en) 2023-06-30 2025-01-02 Merck Patent Gmbh Heterobifunctional compounds for the degradation of kras protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA716118B (en) * 1970-10-05 1972-05-31 Richardson Merrell Inc Contraception
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
IL120266A (en) * 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
ATE206701T1 (de) * 1996-04-19 2001-10-15 American Home Prod Östrogene verbindungen
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive

Also Published As

Publication number Publication date
AU2003204896B2 (en) 2006-06-15
EP1051179A2 (en) 2000-11-15
HRP20000269A2 (en) 2000-12-31
CN1278732A (zh) 2001-01-03
UA68365C2 (en) 2004-08-16
CA2307210A1 (en) 1999-05-20
NZ503890A (en) 2002-08-28
BG104451A (en) 2000-12-29
DE69831605T2 (de) 2006-06-14
WO1999024027A2 (en) 1999-05-20
ZA9810136B (en) 2000-05-05
DK1051179T3 (da) 2005-10-31
AR016667A1 (es) 2001-07-25
CZ294155B6 (cs) 2004-10-13
EE200000211A (et) 2001-04-16
BR9813982A (pt) 2000-09-26
PL340623A1 (en) 2001-02-12
DE69831605D1 (de) 2005-10-20
HUP0100293A2 (hu) 2001-10-28
ES2246541T3 (es) 2006-02-16
EE04092B1 (et) 2003-08-15
EP1051179B1 (en) 2005-09-14
SK6482000A3 (en) 2000-11-07
AU1303199A (en) 1999-05-31
ID24568A (id) 2000-07-27
EA200000492A1 (ru) 2000-10-30
IL135621A0 (en) 2001-05-20
CZ20001661A3 (cs) 2000-12-13
WO1999024027A3 (en) 1999-07-15
TR200001268T2 (tr) 2001-01-22
HUP0100293A3 (en) 2002-12-28
JP2001522798A (ja) 2001-11-20
ATE304359T1 (de) 2005-09-15
GEP20043290B (en) 2004-07-26
NO20002167D0 (no) 2000-04-27
AU760540B2 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
DK1051179T3 (da) Anti-estrogen- plus progestin-holdige orale kontraceptiva
ID20233A (id) Komposisi oral
DE59802860D1 (de) Desinfektionsmittel
EP1072253A4 (en) PREPARATIONS TO BE ORALED
DE59506139D1 (de) Orale Retard-Präparation
MA24473A1 (fr) Formulations
DE59802830D1 (de) Orthesengelenk
NO993096D0 (no) Orale cyklosporinformuleringer
EP0836470A4 (en) ORAL COMPOSITIONS
DE60007530D1 (de) Oral wirksame androgene
DE69827710D1 (de) Kippbecken-WC
DE69805807D1 (de) Mikrobiozide n-sulfonylglycin-alkynyloxyphenethylamid-derivate
ITMI991826A0 (it) Nuova formulazione orale
DE60032510D1 (de) Kondom
DK1334725T3 (da) Östroprogestativt antikonceptionsmiddel
DE69821845D1 (de) Ostomievorrichtung
ID20466A (id) Komposisi oral
ID19885A (id) Tisu lembab
DE69907677D1 (de) Brennstoff-luft-mischgerät
DK0853933T3 (da) Ostomikobling
DE69832127D1 (de) Wässrige Siliconzusammensetzung
ID20328A (id) Toilet
DE69804179D1 (de) Photoempfindliche Zusammensetzung
DE59702106D1 (de) Knabber
DE69823079D1 (de) Bissanzeiger

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application